Browse > Article
http://dx.doi.org/10.4333/KPS.2004.34.6.513

Sensitive Determination of Pinaverium Bromide in Human Plasma by LC-ESI-MS/MS : Applicability to Oral Bioavailability Determination  

Park, Seok (College of Pharmacy, Chung-Ang University)
Lee, Ye-Rie (Seoul Medical Science Institute, Seoul Clinical Laboratories)
Kim, Ho-Hyun (Seoul Medical Science Institute, Seoul Clinical Laboratories)
Lee, Hee-Joo (Seoul Medical Science Institute, Seoul Clinical Laboratories)
Kim, Yoon-Gyoon (College of Medicine, Dankook University)
Youm, Jeong-Rok (College of Pharmacy, Chung-Ang University)
Han, Sang-Beom (College of Pharmacy, Chung-Ang University)
Publication Information
Journal of Pharmaceutical Investigation / v.34, no.6, 2004 , pp. 513-519 More about this Journal
Abstract
A sensitive method for quantification of pinaverium bromide in human plasma was established using liquid chromatography-electrospray ionization tandem mass spectrometry(LC-ESI-MS/MS). Glimepiride was used as internal standard. Pinaverium bromide and internal standard in plasma sample were extracted using tert-butylmethylether(TBME). A centrifuged upper layer was then evaporated and reconstituted with mobile phase of acetonitrile-5 mM ammonium formate (80/20, pH 3.0). The reconstituted samples were injected into a $C_{18}$ reversed-phase column. Using MS/MS with multiple reaction monitoring (MRM) mode, pinaverium and glimepirde were detected without severe interference from human plasma matrix. Pinaverium produced a protonated precursor ion $([M+H]^+)$ at m/z 510.3 and a corresponding product ion at m/z 228.9. Internal standard produced a protonated precursor ion $([M+H]^+)$ at m/z 491.5 and a corresponding product ion at m/z 352.0. Detection of pinaverium bromide in human plasma was accurate and precise, with limit of quantitation at 0.5 ng/ml. The method has been successfully applied to bioavailability study of pinaverium bromide tablet in Korean healthy male volunteers. Pharmacokinetic parameters such as $AUC_t,\;C_{max},\;T_{max},\;K_{el}\;and\;t_{1/2}$ were calculated.
Keywords
Pinaverium bromide; LC-ESI-MS/MS; Bioavailability; Pharmacokinetic parameters;
Citations & Related Records
연도 인용수 순위
  • Reference
1 G.A. de Weerdt, R.P. Beke, H.G. Verdievel, E Barbier, J.A. Ionckheere and A.P. de Leenheer, Quantitative gas chromatographic mass spectrometric determination of pinaverium-bromide in human serum, Biomed. Mass Spectrum., 10, 162-167 (1983)   DOI   ScienceOn
2 C.L. Lu, C.Y. Chen, F.Y. Chang, S.S. Chang, L.J. Kang, RH. Lu and SD Lee, Effect of a calcium channel blocker and antispasmodic in diarrhea-predominant irritable bowel syndrome, J. Gastrsenterol. Hepatol., 15, 925-930 (2000)   DOI   ScienceOn
3 M. Bouchoucha, A. Faye, G. Devroede and M. Arsac, Effect of oral pinaverium bromide on colonic response to food in irritable bowel syndrome patients, Biomed. Pharmacother., 54, 381-387 (2000)   DOI   ScienceOn
4 C. Scarpignato and I. Pelosini, Management of irritable bowel syndrome : novel approaches to the pharmacology of gut motility, Can. J. Gastroenterol., 13, 50A-65A (1999)   DOI
5 Y. Dai, J.X. Liu, J.X. Li and Y.F. Xu, Effect of pinaverium bromide on stress-induced colonic smooth muscle contractility disorder in rats. World J. Gastroenterol., 9, 557-561 (2003)   DOI
6 L.S. Schanker, P.A. Shore, B.B. Brodie and C.A.M. Hogben, Absorption of drugs from the stomach. I. The rat, J. Pharmacol. Exper. Ther., 120, 528-539 (1957)
7 Technical information: Dicetel(R), pinaverium bromide, Solvay Kingswood Inc., Scarborough, Ontario, Canada (1993)
8 식품의약품안전청 고시 제2002-60호, 생물학적동등성시험기준 (2002. 11. 22)